Kit ELISA G-CSF sandwich (CSF3) (mouse): quantitative assay of Ms G-CSF in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms G-CSF.
Kit ELISA G-CSF sandwich (CSF3) (mouse): quantitative assay of Ms G-CSF in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms G-CSF.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
G-CSF (a granulocyte colony stimulant) is a natural cytokine that stimulates the production and antibacterial function of neutrophils and monocytes. Human G-CSF is a 18.8 kDa protein containing 175 amino acid residues and a soluble isoform of the G-CSF receptor has been described. Pleiotropic cytokine is produced by activated monocytes, macrophages, endothelial cells, fibroblasts, astrocytes, osteoblasts, and bone marrow cells. G-CSF has been shown to have specific effects on the proliferation, differentiation and activation of haematopoietic cells. G-CSF is also expressed by different transformed cells such as cancer cells and myeloblast leukemic cells. The G-CSF is encoded by two distinct sequences of the DNA, giving a large-scale high-activity isoform of the G-CSF and a small-scale low-activity isoform. G-CSF is highly conserved among species and has been shown to perform its biological functions through interaction with its receptor, expressed on the surface of hematopoietic progenitors, neutrophil granulocytes and certain cell lines of carcinoma. The clinical use of G-CSF has been approved for several therapeutic applications, for the treatment of neonatal infections, the treatment of acute myocardial infarction, granulocyte transfusion in patients with neutropenia, serious infections and septicaemia, treatment of chronic autoimmune neutropenia, treatment of acute myeloid leukaemia, Sweet syndrome and AIDS. In addition, G-CSF has been shown to be a protein marker for various carcinomas such as bladder cancer, and protein dysfunction has been associated with Kostmann's syndrome.
Sensitivity
Sensitivity of the dosage: 0.5 pg/ml.
Measurement range
Dose range: 0.62-150 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15455243 |
| Specifications |
| Accession number | P09920 |
| Dose range | 0.62-150 pg/ml |
| Sensitivity of the dosage | 0.5 pg/ml |
| Calibration range | 0.5 pg/ml to 150 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Cytokines & receptors |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the cytokines tested: mouse CD30, L CD30, T CD40, CRG-2, CTACK, CXCL16, eotaxin, eotaxin-2, Ligand Fas, fractalkine, GM-CFS, IFN-gamma, IGFBP-3, IGFBP-5, IGFBP-6, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-3 Rb, IL-4, IL-5, IL-6, IL-9, IL-10, |
| Sufficient for | 96 dosages |
| Target species | Mouse |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 12985 |
| Gene symbol(s) | Csfg,G-CSF,MGI-IG |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Immunology |
| Synonym | RP23-395E10.4, Csfg, G-CSF, MGI-IG |
| Target | Mouse |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 5 μl; serum, 5 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMCSF3 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.